TACS on High-inflammatory and Refractory Depression
RecruitingNCT06812923Phase: NAStarted 2025-01-01
Summary
This study is a randomized controlled trial with a duration of 12 weeks (4 weeks of intervention + 8 weeks of follow-up). The participants are patients with treatment-resistant depression (TRD) and hi
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
55 Years
Locations
The 20th ward of general psychiatric departmentTianjin, Tianjin Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06812923